Winway Health Desk

FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta REDWOOD CITY, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ: CHRS), today announced that...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) injection for intravenous use...

Bausch Health Announces U.S. Launch of Bryhali (halobetasol propionate) Lotion, 0.01%, for Plaque Psoriasis In Adults LAVAL, Quebec, Nov. 7, 2018 /PRNewswire/ -- Bausch Health...

RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food and Drug Administration (FDA)...

KENILWORTH, N.J.--(BUSINESS WIRE) November 9, 2018 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and...

FDA Approves Tolsura (SUBA®-itraconazole capsules) for the Treatment of Certain Fungal Infections ADELAIDE, Australia, Dec. 11, 2018 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX)...

On the eve of the last day of the Affordable Care Act’s open enrollment period, a federal judge in Texas has struck down the...

FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin INCHEON, South Korea & JERUSALEM--(BUSINESS WIRE) December 14, 2018 --Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today...

As the Affordable Care Act open enrollment period for 2019 draws to a close, a number of factors have conspired to create what projects...

Posted on December 12th, 2018 by admin in Pharma R&D...